• No se han encontrado resultados

Drug Prescribing in Patients with Impaired Renal Function: are Interventions Still Needed to Improve Patient Safety?

N/A
N/A
Protected

Academic year: 2017

Share "Drug Prescribing in Patients with Impaired Renal Function: are Interventions Still Needed to Improve Patient Safety?"

Copied!
1
0
0

Texto completo

(1)

340 ISSN 0326-2383

KEY WORDS: Chronic kidney disease, Cockcroft-Gault, Drug dosage, Medication error, Modification of diet in renal disease, Pharmaceutical care.

* Author to whom correspondence should be addressed. E-mail: emarino@ub.edu

Latin American Journal of Pharmacy

(formerly

Acta Farmacéutica Bonaerense)

Lat. Am. J. Pharm.

31

(2): 340-3 (2012)

Short communication Received: December 2, 2011 Revised version: March 22, 2012 Accepted: March 25, 2012

Drug Prescribing in Patients with Impaired Renal Function:

are Interventions Still Needed to Improve Patient Safety?

Ana GÓMEZ-LOBÓN

1

, Olga DELGADO-SÁNCHEZ

1

, Pilar MODAMIO

2

,

Laura ÁLVAREZ-ARROYO

1

, Francisco CAMPOAMOR-LADÍN

1

& Eduardo L. MARIÑO

2

*

1

Pharmacy Department. Hospital Universitario Son Espases, Palma de Mallorca (Spain).

2

Clinical Pharmacy and Pharmacotherapy Unit, Department of Pharmacy and Pharmaceutical Technology,

Faculty of Pharmacy, University of Barcelona, Barcelona (Spain).

SUMMARY.An intervention study of 3 months was performed at a third-level university hospital to inves-tigate if drug adjustment interventions towards chronic kidney disease (CKD) patients are still needed. Patients with a glomerular filtration rate < 60 mL/min/1.73 m2and a prescribed medication that needed

Referencias

Documento similar

Liabeuf et al., “Serum indoxyl sul- fate is associated with vascular disease and mortality in chronic kidney disease patients,” Clinical Journal of the American Society of

FiGURe 1 | CD74 functions in renal cells. Glomerular parietal epithelial cells express CD44 when activated and it is thought that CD44 contributes to the proliferative response.

Several systems, molecules and responses involved in the pathogenesis of the pathological fibrosis of chronic kidney disease (CKD) will be discussed in this review, putting

Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure:

Kopple, “Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients,” Clinical Journal of the American Society of Nephrology,

The patients with ADPKD included in the study had worse renal function (worse mean estimated by glomerular filtration rate [eGFR], more in patients with CKD stage 4) and

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk